- Report
- July 2025
- 163 Pages
Global
From €13228EUR$14,999USD£11,451GBP
- Report
- July 2025
- 150 Pages
Global
From €3395EUR$3,850USD£2,939GBP
€4277EUR$4,850USD£3,703GBP
- Report
- July 2025
- 150 Pages
Global
From €3395EUR$3,850USD£2,939GBP
€4277EUR$4,850USD£3,703GBP
- Report
- March 2025
- 150 Pages
Global
From €3395EUR$3,850USD£2,939GBP
€4277EUR$4,850USD£3,703GBP
- Report
- March 2025
- 150 Pages
Global
From €3395EUR$3,850USD£2,939GBP
€4277EUR$4,850USD£3,703GBP
- Report
- February 2025
- 150 Pages
Global
From €3395EUR$3,850USD£2,939GBP
€4277EUR$4,850USD£3,703GBP
- Report
- December 2024
- 150 Pages
Global
From €3395EUR$3,850USD£2,939GBP
€4277EUR$4,850USD£3,703GBP
- Report
- January 2025
- 77 Pages
Global
From €3500EUR$4,251USD£3,136GBP
- Report
- October 2024
- 100 Pages
Global
From €3500EUR$4,251USD£3,136GBP
- Report
- June 2025
- 400 Pages
Global
From €4365EUR$4,949USD£3,778GBP
- Report
- June 2025
- 400 Pages
Global
From €4365EUR$4,949USD£3,778GBP
- Report
- June 2025
- 400 Pages
Global
From €4365EUR$4,949USD£3,778GBP
- Report
- April 2025
- 43 Pages
Global
From €1058EUR$1,200USD£916GBP
- Report
- July 2025
- 350 Pages
Global
From €4365EUR$4,949USD£3,778GBP
- Report
- June 2025
- 400 Pages
Global
From €4365EUR$4,949USD£3,778GBP
- Report
- May 2025
- 220 Pages
Global
From €4405EUR$4,995USD£3,814GBP
- Report
- April 2025
- 179 Pages
Global
From €4405EUR$4,995USD£3,814GBP
- Report
- December 2024
- 150 Pages
Global
From €2961EUR$3,358USD£2,563GBP
€3484EUR$3,950USD£3,016GBP
- Report
- January 2025
- 50 Pages
Global
From €2204EUR$2,499USD£1,908GBP
- Report
- December 2024
- 55 Pages
Global
From €2204EUR$2,499USD£1,908GBP

T Cell Therapies are a type of biotechnology that involves the use of a patient's own T cells to treat diseases. T cells are a type of white blood cell that play a key role in the body's immune system. T Cell Therapies involve the extraction of T cells from a patient, engineering them to recognize and attack specific targets, and then reintroducing them into the patient's body. This type of therapy has been used to treat a variety of cancers, including leukemia, lymphoma, and multiple myeloma. It has also been used to treat autoimmune diseases, such as rheumatoid arthritis and Crohn's disease.
T Cell Therapies are a rapidly growing field of biotechnology, with many companies investing in research and development. Companies such as Kite Pharma, Juno Therapeutics, and Novartis are leading the way in developing and commercializing T Cell Therapies. Other companies, such as Gilead Sciences, Celgene, and Regeneron, are also investing in the field. Show Less Read more